The WJGO is a high-quality, peer reviewed, open-access journal. The primary task of WJGO is to rapidly publish high-quality original articles, reviews, editorials, and case reports in the field of gastrointestinal oncology. In order to promote productive academic communication, the peer review process for the WJGO is transparent; to this end, all published manuscripts are accompanied by the anonymized reviewers’ comments as well as the authors’ responses. The primary aims of the WJGO are to improve diagnostic, therapeutic and preventive modalities and the skills of clinicians and to guide clinical practice in gastrointestinal oncology.
Islet Cell Adenoma, Liver Cell Adenoma, Adenomatous Polyposis Coli, Appendiceal Neoplasms, Bile Duct Neoplasms, Biliary Tract Neoplasms, Hepatocellular Carcinoma, Islet Cell Carcinoma, Pancreatic Ductal Carcinoma, Cecal Neoplasms, Colonic Neoplasms, Colorectal Neoplasms, Hereditary Nonpolyposis Colorectal Neoplasms, Common Bile Duct Neoplasms, Duodenal Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Gardner Syndrome, Gastrinoma, Gastrointestinal Neoplasms, Glucagonoma, Ileal Neoplasms, Insulinoma, Intestinal Neoplasms, Jejunal Neoplasms, Liver Neoplasms, Experimental Liver Neoplasms, Pancreatic Neoplasms, Peritoneal Neoplasms, Rectal Neoplasms, Sigmoid Neoplasms, Somatostatinoma, Stomach Neoplasms, and Vipoma.